PSB-SB-1202|  | 
|
| 
7-pentyl-5-methoxy-3-(2-methoxybenzyl)-2H-chromen-2-one
 | 
| CAS Number |  | 
|---|
| PubChem CID |  | 
|---|
| ChemSpider |  | 
|---|
| UNII |  | 
|---|
| CompTox Dashboard (EPA) |  | 
|---|
|
| Formula | C23H26O4 | 
|---|
| Molar mass | 366.457 g·mol−1 | 
|---|
| 3D model (JSmol) |  | 
|---|
| 
O=C1C(CC2=C(OC)C=CC=C2)=CC3=C(C=C(CCCCC)C=C3OC)O1
 | 
| 
InChI=1S/C23H26O4/c1-4-5-6-9-16-12-21(26-3)19-15-18(23(24)27-22(19)13-16)14-17-10-7-8-11-20(17)25-2/h7-8,10-13,15H,4-6,9,14H2,1-3H3Key:VZYCAUIYIZSPQY-UHFFFAOYSA-N
 | 
PSB-SB-1202 is a coumarin derivative which is an agonist at the cannabinoid receptors CB1 and CB2, with a CB1 Ki of 32nM and a CB2 Ki of 49nM.[1] It is also a weak antagonist at the related receptor GPR55, with an IC50 of 6350nM, but has no significant affinity for GPR18.[2]
See also
References
- ^ Rempel V, Volz N, Hinz S, Karcz T, Meliciani I, Nieger M, et al. (September 2012). "7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists". Journal of Medicinal Chemistry. 55 (18): 7967–77. doi:10.1021/jm3008213. PMID 22916707.
- ^ Rempel V, Volz N, Gläser F, Nieger M, Bräse S, Müller CE (June 2013). "Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold". Journal of Medicinal Chemistry. 56 (11): 4798–810. doi:10.1021/jm4005175. PMID 23679955.
 
|  | 
|---|
| Phytocannabinoids (comparison)
 | | Cannabibutols |  | 
|---|
 | Cannabichromenes |  | 
|---|
 | Cannabicyclols |  | 
|---|
 | Cannabidiols |  | 
|---|
 | Cannabielsoins |  | 
|---|
 | Cannabigerols |  | 
|---|
 | Cannabiphorols |  | 
|---|
 | Cannabinols | 
CBN
CBNACBN-C1CBN-C2CBN-C4CBNM
CBND
CBNP
CBVD
 | 
|---|
 | Cannabitriols |  | 
|---|
 | Cannabivarins |  | 
|---|
 | Delta-3-tetrahydrocannabinols |  | 
|---|
 | Delta-4-tetrahydrocannabinols |  | 
|---|
 | Delta-7-tetrahydrocannabinols |  | 
|---|
 | Delta-8-tetrahydrocannabinols |  | 
|---|
 | Delta-9-tetrahydrocannabinols |  | 
|---|
 | Delta-10-Tetrahydrocannabinols |  | 
|---|
 | Delta-11-Tetrahydrocannabinols |  | 
|---|
 | Miscellaneous cannabinoids |  | 
|---|
 | Active metabolites |  | 
|---|
 | 
|---|
| Endocannabinoids |  | 
|---|
| Synthetic cannabinoid
 receptor
 agonists /
 neocannabinoids
 | | Classical cannabinoids (dibenzopyrans)
 |  | 
|---|
 | Non-classical cannabinoids
 |  | 
|---|
 | Adamantoylindoles |  | 
|---|
 | Benzimidazoles |  | 
|---|
 | Benzoylindoles |  | 
|---|
 | Cyclohexylphenols |  | 
|---|
 | Eicosanoids |  | 
|---|
 | Indazole-3- carboxamides
 |  | 
|---|
 | Indole-3-carboxamides |  | 
|---|
 | Indole-3-carboxylates |  | 
|---|
 | Naphthoylindazoles |  | 
|---|
 | Naphthoylindoles |  | 
|---|
 | Naphthoylpyrroles |  | 
|---|
 | Naphthylmethylindenes |  | 
|---|
 | Naphthylmethylindoles |  | 
|---|
 | Phenylacetylindoles |  | 
|---|
 | Pyrazolecarboxamides |  | 
|---|
 | Tetramethylcyclo- propanoylindazoles
 |  | 
|---|
 | Tetramethylcyclo- propanoylindoles
 |  | 
|---|
 | Others |  | 
|---|
 | 
|---|
| Allosteric CBRTooltip Cannabinoid receptor ligands |  | 
|---|
| Endocannabinoid enhancers
 (inactivation inhibitors)
 |  | 
|---|
| Anticannabinoids (antagonists/inverse
 agonists/antibodies)
 |  | 
|---|
|  |